# Ozempic (semaglutide): Dosage, Side Effects & Uses

Source: https://pepvault.app/drugs/ozempic

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Brand-name drugs](https://pepvault.app/drugs) Ozempic

Brand-name drug · GLP-1 receptor agonist

# Ozempic (semaglutide)

From the FDA label, read Nov 18, 2026 [Published by PepVault](https://pepvault.app/guides/how-we-research)

Ozempic is a prescription medicine from Novo Nordisk whose active ingredient is semaglutide, sold both as a once-weekly injection and as a once-daily tablet.

FDA approved it, together with diet and exercise, to improve blood sugar control in adults with type 2 diabetes, and to lower the risk of heart attack, stroke and heart-related death in adults with type 2 diabetes who have heart disease or are at high risk.

- **Active ingredient:** [Semaglutide](https://pepvault.app/peptides/semaglutide), [Semaglutide (oral)](https://pepvault.app/peptides/semaglutide-oral)
- **Maker:** Novo Nordisk
- **Class:** GLP-1 receptor agonist
- **FDA application:** [NDA 209637](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209637), first approved 2017

## What FDA approved it for

The injection carries three approved uses: blood sugar control in adults with type 2 diabetes; lowering the risk of major heart events in adults with type 2 diabetes and established heart disease; and lowering the risk of kidney decline, kidney failure and heart-related death in adults with type 2 diabetes and chronic kidney disease.

Ozempic tablets share one label with Rybelsus. They are approved for blood sugar control in adults with type 2 diabetes and to lower the risk of major heart events in adults with type 2 diabetes at high risk of them; the kidney use belongs to the injection alone.

From the label: 1 Indications and Usage.

## How it is supplied

Ozempic’s forms and the doses each one gives, as the label lists them

| Form | Doses |
| --- | --- |
| Multi-dose pen (4 weekly doses) | 0.25 mg or 0.5 mg, 1 mg, 2 mg |
| Single-dose prefilled syringe | 0.25 mg, 0.5 mg, 1 mg |
| Tablet | 1.5 mg, 4 mg, 9 mg |

From the label: 3 Dosage Forms and Strengths.

## The label’s dosing schedule

This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.

### Ozempic injection, once a week

Ozempic’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.

Ozempic injection, once a week: the steps on the label. Highest dose: 2 mg a week.

| Dose | When, on the label |
| --- | --- |
| 0.25 mg a week | Weeks 1 to 4 |
| 0.5 mg a week | After the first 4 weeks |
| 1 mg a week | After at least 4 weeks on 0.5 mg, if needed |
| 2 mg a week | After at least 4 weeks on 1 mg, if needed |

The first month at 0.25 mg is there to lower the chance of stomach side effects; the label places the lasting dose at 0.5 mg, 1 mg or 2 mg, chosen by how blood sugar responds.

For adults with type 2 diabetes and chronic kidney disease, the label sets the lasting dose at 1 mg a week, reached after at least 4 weeks on 0.5 mg.

### Ozempic tablets, once a day

Ozempic’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.

Ozempic tablets, once a day: the steps on the label. Highest dose: 9 mg a day.

| Dose | When, on the label |
| --- | --- |
| 1.5 mg a day | Days 1 to 30 |
| 4 mg a day | Days 31 to 60 |
| 9 mg a day | From day 61, if more control is needed |

The 1.5 mg tablet is a starting step only; the label says it does not control blood sugar on its own.

Someone on the 0.5 mg weekly injection can move to the tablets: the label starts 4 mg or 9 mg tablets one week after the last shot.

From the label: 2.2 Recommended Dosage; 2.2 Recommended Starting, Escalation and Maintenance Dosage of RYBELSUS and OZEMPIC Tablets; 2.4 Switching from OZEMPIC Injection to RYBELSUS or OZEMPIC Tablets.

## How it’s taken

The injection goes under the skin of the belly, thigh or upper arm once a week, on the same day each week, at any time of day, with or without food. The label asks for a different spot each week when the same area is used.

The weekly day can move, as long as at least 2 days pass between two doses.

An Ozempic tablet is swallowed whole each morning on an empty stomach with up to 4 ounces of plain water, and the label asks for a wait of at least 30 minutes before food, drinks or other pills.

From the label: 2.1 Important Administration Instructions.

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## If a dose is missed

A missed weekly injection is taken as soon as possible within 5 days. Past 5 days, the label skips it and the next dose comes on the usual day.

A missed tablet is skipped, and the next one is taken the following day.

From the label: 2.1 Important Administration Instructions.

## Storage

A new pen stays in the fridge at 36°F to 46°F and must never be frozen. Once in use, a pen keeps for 56 days at room temperature (59°F to 86°F) or in the fridge, with the cap on and no needle attached.

The prefilled syringes live in the fridge too, and can spend up to 28 days at 46°F to 86°F if needed.

Ozempic tablets sit at room temperature, 68°F to 77°F, in the bottle they came in.

From the label: 16 How Supplied/Storage and Handling.

## Side effects and warnings

Adverse reactions in at least 5% of people on the Ozempic injection in the placebo-controlled trials (adults with type 2 diabetes). Percent of people.

| Reaction | Placebo | 0.5 mg | 1 mg |
| --- | --- | --- | --- |
| Nausea | 6.1 | 15.8 | 20.3 |
| Vomiting | 2.3 | 5 | 9.2 |
| Diarrhea | 1.9 | 8.5 | 8.8 |
| Abdominal pain | 4.6 | 7.3 | 5.7 |
| Constipation | 1.5 | 5 | 3.1 |

Most of the nausea, vomiting and diarrhea came while the dose was being raised. Stomach side effects led 3.1% of people on 0.5 mg and 3.8% on 1 mg to stop, against 0.4% on placebo.

### The boxed warning

**Boxed warning: “RISK OF THYROID C-CELL TUMORS”**The label opens with a boxed warning on the risk of thyroid C-cell tumors. Semaglutide caused these tumors in rodents; whether it does in people is not known. The label rules Ozempic out for anyone with a personal or family history of medullary thyroid carcinoma or with MEN 2.

### The other warnings

Its other warnings cover pancreatitis, eye changes from diabetic retinopathy, low blood sugar when taken with insulin or sulfonylureas, kidney injury from fluid loss, severe stomach side effects, allergic reactions, gallbladder problems and food in the lungs under anesthesia. An Ozempic pen is never shared between people, even with a new needle.

From the label: 6.1 Clinical Trials Experience; Boxed Warning; 5 Warnings and Precautions.

## How Ozempic differs from Wegovy and Rybelsus

Ozempic, Wegovy and Rybelsus hold the same active ingredient, semaglutide. What sets them apart is on their labels: what each is approved for, the forms it comes in and how high its schedule goes.

Semaglutide brands, label against label

| Compared | [Ozempic](https://pepvault.app/drugs/ozempic) | [Wegovy](https://pepvault.app/drugs/wegovy) | [Rybelsus](https://pepvault.app/drugs/rybelsus) |
| --- | --- | --- | --- |
| Approved for | Type 2 diabetes; heart and kidney risk in type 2 diabetes | Weight reduction; heart risk with obesity; MASH (injection) | Type 2 diabetes; heart risk in type 2 diabetes |
| Forms | Multi-dose pen; Single-dose prefilled syringe; Tablet | Single-dose pen; Single-dose syringe; FlexTouch pen; Tablet | Tablet |
| Label’s dose range | injection: 0.25 mg to 2 mg once a week; tablets: 1.5 mg to 9 mg once a day | injection: 0.25 mg to 7.2 mg once a week; tablets: 1.5 mg to 25 mg once a day | 3 mg to 14 mg once a day |
| Top dose | 2 mg a week; 9 mg a day | 7.2 mg a week; 25 mg a day | 14 mg a day |
| Maker | Novo Nordisk | Novo Nordisk | Novo Nordisk |

[Ozempic vs Wegovy: the two labels side by side](https://pepvault.app/drugs/compare/ozempic-vs-wegovy)

[Ozempic vs Rybelsus: the two labels side by side](https://pepvault.app/drugs/compare/ozempic-vs-rybelsus)

## What else we have on semaglutide

### Semaglutide on PepVault

- [Semaglutide in the peptide library](https://pepvault.app/peptides/semaglutide)
- [Semaglutide (oral) in the peptide library](https://pepvault.app/peptides/semaglutide-oral)
- [Semaglutide: half-life](https://pepvault.app/peptides/semaglutide/half-life)
- [Semaglutide: side effects](https://pepvault.app/peptides/semaglutide/side-effects)
- [Semaglutide: how long it takes to work](https://pepvault.app/peptides/semaglutide/how-long-to-work)
- [Semaglutide (oral): half-life](https://pepvault.app/peptides/semaglutide-oral/half-life)
- [Semaglutide (oral): side effects](https://pepvault.app/peptides/semaglutide-oral/side-effects)
- [Is Semaglutide legal? FDA, DEA and WADA status](https://pepvault.app/peptides/semaglutide/legal-status)
- [Is Semaglutide (oral) legal? FDA, DEA and WADA status](https://pepvault.app/peptides/semaglutide-oral/legal-status)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)
- [Semaglutide (oral) dose guide](https://pepvault.app/lab/dosage/semaglutide-oral)

### Free tools

- [GLP-1 titration calculator](https://pepvault.app/tools/glp1-titration-calculator)
- [Missed a GLP-1 dose?](https://pepvault.app/tools/missed-glp1-dose)
- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The trials, in plain English

- [Semaglutide: 6.6% vs 8.9% heart or stroke events in SUSTAIN-6](https://pepvault.app/research/semaglutide-sustain-6-2016)
- [Semaglutide: 24% lower risk of major kidney events in FLOW](https://pepvault.app/research/semaglutide-flow-2024)
- [Dulaglutide cut HbA1c and weight less than semaglutide in SUSTAIN 7](https://pepvault.app/research/dulaglutide-sustain-7-2018)

### Brand against brand

- [Ozempic vs Wegovy](https://pepvault.app/drugs/compare/ozempic-vs-wegovy)
- [Ozempic vs Rybelsus](https://pepvault.app/drugs/compare/ozempic-vs-rybelsus)
- [Ozempic vs Mounjaro](https://pepvault.app/drugs/compare/ozempic-vs-mounjaro)
- [Ozempic vs Zepbound](https://pepvault.app/drugs/compare/ozempic-vs-zepbound)
- [Ozempic vs Victoza](https://pepvault.app/drugs/compare/ozempic-vs-victoza)
- [Ozempic vs Trulicity](https://pepvault.app/drugs/compare/ozempic-vs-trulicity)

### Compound against compound

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)
- [Semaglutide vs Semaglutide (oral)](https://pepvault.app/peptides/compare/semaglutide-vs-semaglutide-oral)
- [CagriSema vs Semaglutide](https://pepvault.app/peptides/compare/cagrisema-vs-semaglutide)
- [5-Amino-1MQ vs Semaglutide](https://pepvault.app/peptides/compare/5-amino-1mq-vs-semaglutide)
- [Semaglutide vs BPC-157](https://pepvault.app/peptides/compare/semaglutide-vs-bpc-157)
- [Semaglutide vs Exenatide](https://pepvault.app/peptides/compare/semaglutide-vs-exenatide)
- [Semaglutide vs Amycretin](https://pepvault.app/peptides/compare/semaglutide-vs-amycretin)
- [Semaglutide vs Petrelintide](https://pepvault.app/peptides/compare/semaglutide-vs-petrelintide)
- [Semaglutide vs Ecnoglutide](https://pepvault.app/peptides/compare/semaglutide-vs-ecnoglutide)
- [Semaglutide vs Efinopegdutide](https://pepvault.app/peptides/compare/semaglutide-vs-efinopegdutide)
- [Orforglipron vs Semaglutide (oral)](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide-oral)

## Questions about Ozempic

### What is the starting dose of Ozempic?

The label starts the injection at 0.25 mg once a week for 4 weeks, then raises it to 0.5 mg. The tablets’ first step is 1.5 mg once a day for 30 days. Your prescriber sets the schedule.

### What is the highest dose of Ozempic?

The label’s maximum for the injection is 2 mg once a week. For the tablets, the schedule tops out at 9 mg once a day.

### What if I miss an Ozempic injection?

The label says to take it as soon as possible within 5 days. If more than 5 days have passed, skip it and take the next dose on the usual day.

### How long does an Ozempic pen last out of the fridge?

After its first use, the label lets a pen be kept for 56 days at room temperature, 59°F to 86°F, or in the fridge.

### Is Ozempic approved for weight loss?

No. Its approved uses are blood sugar control in adults with type 2 diabetes and lowering heart and kidney risks in some of those adults. The semaglutide brand approved for weight is Wegovy.

## Sources

- [OZEMPIC (semaglutide) injection, for subcutaneous use, FDA label on DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79) (version 20, published Jun 10, 2026; read Nov 18, 2026)
- [RYBELSUS (semaglutide) tablets and OZEMPIC (semaglutide) tablets, for oral use, FDA label on DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98) (version 14, published Aug 19, 2026; read Nov 18, 2026)
- [Drugs@FDA, NDA 209637](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209637) (Ozempic, the injection; application first approved 2017)
- [Drugs@FDA, NDA 213051](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213051) (Ozempic, the tablets, added to the application by supplement 30 on Jan 30, 2026; application first approved 2019)

PepVault is not affiliated with Novo Nordisk. Ozempic is a trademark of its owner.

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## More on semaglutide

### Semaglutide on PepVault

- [Semaglutide in the peptide library](https://pepvault.app/peptides/semaglutide)
- [Semaglutide (oral) in the peptide library](https://pepvault.app/peptides/semaglutide-oral)
- [Semaglutide: half-life](https://pepvault.app/peptides/semaglutide/half-life)
- [Semaglutide: side effects](https://pepvault.app/peptides/semaglutide/side-effects)
- [Semaglutide: how long it takes to work](https://pepvault.app/peptides/semaglutide/how-long-to-work)
- [Semaglutide (oral): half-life](https://pepvault.app/peptides/semaglutide-oral/half-life)
- [Semaglutide (oral): side effects](https://pepvault.app/peptides/semaglutide-oral/side-effects)
- [Is Semaglutide legal? FDA, DEA and WADA status](https://pepvault.app/peptides/semaglutide/legal-status)
- [Is Semaglutide (oral) legal? FDA, DEA and WADA status](https://pepvault.app/peptides/semaglutide-oral/legal-status)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)
- [Semaglutide (oral) dose guide](https://pepvault.app/lab/dosage/semaglutide-oral)

### Free tools

- [GLP-1 titration calculator](https://pepvault.app/tools/glp1-titration-calculator)
- [Missed a GLP-1 dose?](https://pepvault.app/tools/missed-glp1-dose)
- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The trials, in plain English

- [Semaglutide: 6.6% vs 8.9% heart or stroke events in SUSTAIN-6](https://pepvault.app/research/semaglutide-sustain-6-2016)
- [Semaglutide: 24% lower risk of major kidney events in FLOW](https://pepvault.app/research/semaglutide-flow-2024)
- [Dulaglutide cut HbA1c and weight less than semaglutide in SUSTAIN 7](https://pepvault.app/research/dulaglutide-sustain-7-2018)

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Brand-name drugs

- [Every brand, by ingredient](https://pepvault.app/drugs)
- [Wegovy](https://pepvault.app/drugs/wegovy)
- [Rybelsus](https://pepvault.app/drugs/rybelsus)
- [Ozempic vs Wegovy](https://pepvault.app/drugs/compare/ozempic-vs-wegovy)
- [Ozempic vs Rybelsus](https://pepvault.app/drugs/compare/ozempic-vs-rybelsus)
- [Ozempic vs Mounjaro](https://pepvault.app/drugs/compare/ozempic-vs-mounjaro)

## The library

- [Semaglutide in the peptide library](https://pepvault.app/peptides/semaglutide)
- [Semaglutide (oral) in the peptide library](https://pepvault.app/peptides/semaglutide-oral)
- [The peptide reference library](https://pepvault.app/peptides)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. PepVault is not affiliated with Novo Nordisk. Ozempic is a trademark of its owner.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
